• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经直肠超声引导下前列腺穿刺活检与根治性前列腺切除术之间Gleason评分升级的发生率及预测变量。

Incidence and variables predicting Gleason score up-grading between trans-rectal ultrasound-guided prostate biopsies and radical prostatectomy.

作者信息

Bright Elizabeth, Manuel Clare, Goddard Jonathan C, Khan Masood A

机构信息

Department of Urology, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, UK.

出版信息

Urol Int. 2010;84(2):180-4. doi: 10.1159/000277595. Epub 2010 Mar 4.

DOI:10.1159/000277595
PMID:20215822
Abstract

OBJECTIVE

To determine whether Gleason score up-grading is still occurring in men diagnosed with adenocarcinoma of the prostate via extended biopsy regimens, and factors that might predict this.

PATIENTS AND METHODS

Between September 1999 and February 2007, 211 men (age: 42-70 years; mean: 60 years) underwent trans-rectal ultrasound-guided prostate biopsies confirming clinically localized adenocarcinoma followed by radical prostatectomy (RP), within our department. Univariate and multivariate logistic regression (LR) analyses using age, serum PSA, prostate volume, clinical stage and total length of cores taken were performed to determine whether Gleason score up-grading could be predicted.

RESULTS

A total of 7/20 (35%), 24/64 (38%) and 36/127 (28%) men with 6, 7-9 and at least 10 core biopsies experienced Gleason score up-grading (p = nonsignificant between the 3 groups). Both univariate and multivariate LR analyses failed to determine any of our variables as a predictor of Gleason score up-grading from biopsy to RP.

CONCLUSION

Despite increasing the number of cores taken at biopsy, in order to improve prostate cancer diagnosis, a substantial percentage of men still experience Gleason score up-grading from biopsy to RP. In addition, we were unable to determine any predicting factors for this up-grading.

摘要

目的

确定通过扩展活检方案诊断为前列腺腺癌的男性患者中是否仍会出现Gleason评分升级,以及可能预测这种情况的因素。

患者与方法

1999年9月至2007年2月期间,211名男性(年龄42 - 70岁;平均60岁)在我科接受经直肠超声引导下前列腺活检,确诊为临床局限性腺癌,随后接受根治性前列腺切除术(RP)。采用年龄、血清前列腺特异性抗原(PSA)、前列腺体积、临床分期和所取活检组织总长度进行单因素和多因素逻辑回归(LR)分析,以确定是否可以预测Gleason评分升级。

结果

分别进行了6针、7 - 9针和至少10针活检的男性患者中,出现Gleason评分升级的比例分别为7/20(35%)、24/64(38%)和36/127(28%)(三组之间p值无统计学意义)。单因素和多因素LR分析均未能确定我们所研究的任何变量可作为从活检到RP过程中Gleason评分升级的预测指标。

结论

尽管增加了活检针数以改善前列腺癌诊断,但仍有相当比例的男性患者从活检到RP过程中出现Gleason评分升级。此外,我们无法确定这种升级的任何预测因素。

相似文献

1
Incidence and variables predicting Gleason score up-grading between trans-rectal ultrasound-guided prostate biopsies and radical prostatectomy.经直肠超声引导下前列腺穿刺活检与根治性前列腺切除术之间Gleason评分升级的发生率及预测变量。
Urol Int. 2010;84(2):180-4. doi: 10.1159/000277595. Epub 2010 Mar 4.
2
Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.对于接受广泛经直肠超声引导活检方案诊断的低危前列腺癌患者,单侧阳性活检并不能预测根治性前列腺切除术后的单侧前列腺癌。
BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.
3
Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.前列腺腺癌,核心穿刺活检 Gleason 评分 9-10:与根治性前列腺切除术的相关性及预后。
J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056. Epub 2013 May 30.
4
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.前列腺特异性抗原(PSA)密度预测初始前列腺活检和前列腺切除术中 Gleason 评分升级的能力随着肿瘤分级的增加而降低,这是由于单位肿瘤体积的 PSA 分泌减少所致。
BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.
5
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.扩展前列腺活检方案提高了 Gleason 分级的可靠性:对放疗患者的影响
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014.
6
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.前列腺穿刺活检标本中癌阳性核心的百分比强烈预测根治性前列腺切除术中的肿瘤分期和体积。
J Urol. 2000 Jan;163(1):174-8.
7
Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?在适合进行主动监测的患者中,前列腺活检中的累积前列腺癌长度(CCL)能否改善对根治性前列腺切除术中临床意义不显著癌症的预测?
BJU Int. 2015 Aug;116(2):220-9. doi: 10.1111/bju.12880. Epub 2014 Dec 15.
8
The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.前列腺穿刺活检癌灶在穿刺活检受累更严重一侧的百分比作为根治性前列腺切除术后前列腺特异性抗原复发的预测指标:来自共享平等准入区域癌症医院(SEARCH)数据库的结果
Cancer. 2003 Dec 1;98(11):2344-50. doi: 10.1002/cncr.11809.
9
Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.磁共振成像-经直肠超声图像融合活检能准确描绘出目标肿瘤:与 135 例患者的分段式根治性前列腺切除术标本的相关性。
Eur Urol. 2015 Apr;67(4):787-94. doi: 10.1016/j.eururo.2014.08.077. Epub 2014 Sep 17.
10
Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?穿刺活检 Gleason 评分为 7 分的前列腺癌:Gleason 评分 4+3 和 3+4 的预后差异是否独立于受累穿刺针数?
J Urol. 2002 Jun;167(6):2440-2.

引用本文的文献

1
Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores.预测活检核心评分为Gleason≤6的前列腺癌患者患有高级别疾病的风险。
World J Urol. 2015 Jun;33(6):787-92. doi: 10.1007/s00345-014-1348-8. Epub 2014 Jul 2.
2
Does the time from biopsy to radical prostatectomy affect Gleason score upgrading in patients with clinical t1c prostate cancer?对于临床T1c期前列腺癌患者,从活检到根治性前列腺切除术的时间会影响 Gleason 评分升级吗?
Korean J Urol. 2014 Jun;55(6):395-9. doi: 10.4111/kju.2014.55.6.395. Epub 2014 Jun 16.
3
Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6.
前列腺活检Gleason评分≤6的患者中Gleason评分升级的预测因素。
Can Urol Assoc J. 2014 May;8(5-6):E342-6. doi: 10.5489/cuaj.1499.
4
Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease.精浆作为前列腺癌肽生物标志物候选物的来源,用于检测惰性和进展性疾病。
PLoS One. 2013 Jun 24;8(6):e67514. doi: 10.1371/journal.pone.0067514. Print 2013.